Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy: a Randomised, Comparative, Open-label Trial

NCT03188445 is registered in ClinicalTrials.gov with Pharmacosmos A/S as lead sponsor.

NCT NCT03188445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy: a Randomised, Comparative, Open-label Trial
Lead sponsor
Pharmacosmos A/S
Phase
Phase 4
Overall status
Completed
Start date
July 11, 2017
Completion date
August 18, 2020
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia of pregnancy